Author

Jian-Nan Liu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Efficacy and Safety of First‐Line Treatment Options for Oncogene Wild‐Type Lung Adenocarcinoma With Liver Metastases

Liver metastasis represents one of the frequent drivers for cancer‐related mortality in lung adenocarcinoma. For advanced lung adenocarcinoma harboring wild‐type oncogene drivers, chemotherapies in combination with immune checkpoint inhibitors (ICIs) and/or bevacizumab (named IC, BC, and IBC, respectively) are alternat...

Jie Li, Yi-Hui Ge, Qiao-Hong Liu et al. · Cancer Medicine · 0 citations

Case report Open access Sep 2026

Sacituzumab govitecan combined with anlotinib in metastatic triple negative breast cancer patient with repeated pleural effusion: a case report

Metastatic triple-negative breast cancer (mTNBC) is an aggressive malignancy with limited targeted therapeutic alternatives and dismal long-term prognosis. Sacituzumab govitecan (SG) is a Trop-2-directed antibody-drug conjugate (ADC) conjugated to the topoisomerase I inhibitor SN-38. SG has demonstrated robust anti-tum...

Cong-Cong Wang, L. Xu, Hao Han et al. · Frontiers in Pharmacology · 0 citations